X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (92) 92
male (85) 85
index medicus (76) 76
aged (51) 51
animals (50) 50
female (50) 50
middle aged (34) 34
oxidative stress (34) 34
aged, 80 and over (32) 32
rats (30) 30
geriatrics & gerontology (24) 24
internal medicine (24) 24
risk factors (23) 23
alzheimer's disease (22) 22
mitochondria (22) 22
glutathione - metabolism (21) 21
rats, wistar (21) 21
adult (20) 20
dementia (20) 20
oxidation-reduction (20) 20
aging (19) 19
pharmacology & pharmacy (19) 19
biochemistry & molecular biology (18) 18
glutathione (16) 16
liver - metabolism (16) 16
lipid-peroxidation (15) 15
physiological aspects (15) 15
analysis (14) 14
disease (14) 14
gastroenterology & hepatology (14) 14
medicine & public health (14) 14
mitochondria, liver - metabolism (14) 14
proteins (14) 14
liver (13) 13
medicine, general & internal (13) 13
neurosciences (13) 13
inflammation (12) 12
liver - pathology (12) 12
medicine (12) 12
mortality (12) 12
cell biology (11) 11
endocrinology & metabolism (11) 11
fatty acids (11) 11
liver - drug effects (11) 11
mild cognitive impairment (11) 11
risk (11) 11
atherosclerosis (10) 10
disease progression (10) 10
elderly (10) 10
health aspects (10) 10
lipid peroxidation (10) 10
malondialdehyde - metabolism (10) 10
metabolism (10) 10
mitochondria - metabolism (10) 10
oxidative stress - drug effects (10) 10
prevalence (10) 10
age factors (9) 9
alzheimers-disease (9) 9
association (9) 9
case-control studies (9) 9
italy (9) 9
reactive oxygen species - metabolism (9) 9
free radicals (8) 8
logistic models (8) 8
medicine, research & experimental (8) 8
metabolic syndrome (8) 8
mice (8) 8
research (8) 8
ultrasonography (8) 8
vascular dementia (8) 8
a-beta (7) 7
alzheimer disease - genetics (7) 7
biology (7) 7
development and progression (7) 7
diet (7) 7
drug therapy (7) 7
fatty liver - metabolism (7) 7
italy - epidemiology (7) 7
lipid metabolism (7) 7
lipids (7) 7
liver diseases (7) 7
medical research (7) 7
mediterranean diet (7) 7
obesity (7) 7
oncology (7) 7
plasma (7) 7
rat-liver (7) 7
severity of illness index (7) 7
vascular risk-factors (7) 7
adenosine triphosphate - metabolism (6) 6
age (6) 6
aged patients (6) 6
aging - physiology (6) 6
alzheimer disease - metabolism (6) 6
alzheimer disease - pathology (6) 6
alzheimer’s disease (6) 6
amyloid beta-peptides - metabolism (6) 6
antioxidants (6) 6
cholesterol (6) 6
cognition disorders - epidemiology (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Geriatric Psychiatry, ISSN 1064-7481, 2010, Volume 18, Issue 2, pp. 98 - 116
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 01/2019, Volume 20, Issue 1, p. 49
Chronic hepatitis C is associated with a high risk of developing hepatocellular carcinoma (HCC) because of a direct effect of the Hepatitis C Virus (HCV)... 
Hepatocellular carcinoma | Direct-acting antivirals | INTERFERON-FREE THERAPY | BIOCHEMISTRY & MOLECULAR BIOLOGY | HEPATITIS-C-VIRUS | CHRONIC VIRAL-INFECTION | CHEMISTRY, MULTIDISCIPLINARY | direct-acting antivirals | SUSTAINED VIROLOGICAL RESPONSE | TUMOR-NECROSIS-FACTOR | HEPATOCELLULAR-CARCINOMA | SINGLE-SOURCE OUTBREAK | CELLULAR IMMUNE-RESPONSES | REGULATORY T-CELLS | hepatocellular carcinoma | ENDOTHELIAL GROWTH-FACTOR | Carcinoma, Hepatocellular - epidemiology | Hepacivirus - immunology | Humans | Neoplasm Recurrence, Local - virology | Hepatitis C, Chronic - virology | Neoplasm Recurrence, Local - drug therapy | Interferons - therapeutic use | Incidence | Neoplasm Recurrence, Local - immunology | Liver Neoplasms - epidemiology | Carcinoma, Hepatocellular - drug therapy | Carcinoma, Hepatocellular - immunology | Hepatitis C, Chronic - epidemiology | Hepacivirus - drug effects | Liver Neoplasms - virology | Antiviral Agents - therapeutic use | Neutrophils - drug effects | Liver Neoplasms - drug therapy | Liver Neoplasms - immunology | Carcinoma, Hepatocellular - virology | Hepatitis C, Chronic - drug therapy | Monocytes - drug effects | Animals | Hepatitis C, Chronic - immunology | Macrophages - drug effects | Neoplasm Recurrence, Local - epidemiology | Transcription factors | Senescence | PD-1 protein | Interleukin | Homeostasis | Effector cells | Cytotoxicity | Viruses | Lymphocytes T | Infections | Caspase-3 | Cancer therapies | Proteins | Liver cancer | Hepatitis | CTLA-4 protein | Lymphocytes | Antiviral activity | CD25 antigen | Foxp3 protein | Natural killer cells | Growth factors | Immune system | Antigens | Cytokines | Immunoregulation | Mortality | Immunosurveillance | Inflammation | Ribonucleic acid--RNA | CD4 antigen | Molecular modelling | Surveillance | Cell death | PD-L1 protein | Fibrosis | Interleukin 10 | Interferon | Hepatitis C virus | Hepatitis C | Retinoblastoma | Viral infections | Apoptosis
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2016, Volume 11, Issue 12, p. e0167934
Background Novel direct-acting antivirals (DAAs) have completely changed the panorama of hepatitis C due to their high efficacy and optimal safety profile.... 
ANGIOGENESIS | EFFICACY | SOFOSBUVIR | CIRRHOSIS | MULTIDISCIPLINARY SCIENCES | C VIRUS-INFECTION | GENE-EXPRESSION | RIBAVIRIN | HEPATITIS-C | LEDIPASVIR | ENDOTHELIAL GROWTH-FACTOR | Hepatitis C - drug therapy | Human Umbilical Vein Endothelial Cells - metabolism | Humans | Middle Aged | Tumor Necrosis Factor-alpha - blood | Vascular Endothelial Growth Factor A - blood | Interleukin-10 - blood | Male | Antiviral Agents - administration & dosage | Epidermal Growth Factor - blood | Hepacivirus - metabolism | Inflammation - blood | Neoplasms | Inflammation - drug therapy | Antiviral Agents - adverse effects | Hepatitis C - blood | Aged, 80 and over | Adult | Female | Aged | Cell Proliferation - drug effects | Antiviral agents | Complications and side effects | Liver cancer | Hepatitis C | Drug therapy | Vascular endothelial growth factor | Health aspects | Risk factors | Therapy | Interleukin | Hepatocellular carcinoma | Infections | Cancer therapies | Hepatitis | Angiogenesis | Biological effects | Cell growth | Epidermal growth factor | Interleukins | Hepatology | Pretreatment | Immune system | Liver diseases | Cytokines | Internal medicine | Inflammation | Tumor necrosis factor-α | Gene expression | Patients | Endothelial cells | Medicine | Hypotheses | Interleukin 10 | Interferon | Hepatitis C virus | Umbilical vein | Viral infections
Journal Article
Giornale di Gerontologia, ISSN 0017-0305, 2015, Volume 63, Issue 1, pp. 1 - 2
Journal Article
Nutrients, ISSN 2072-6643, 12/2019, Volume 12, Issue 1, p. 35
The aging population is rapidly increasing all over the world. This results in significant implications for the planning and provision of health and social... 
Aging
Journal Article
Journal of Alzheimer's Disease, ISSN 1387-2877, 01/2009, Volume 16, Issue 3, pp. 467 - 470
Very recent findings confirmed that S-adenosylmethionine (SAM) can exert a direct effect on glutathione S-transferase (GST) activity. Alzheimer's disease (AD)... 
Journal Article
Journal of Alzheimer's Disease, ISSN 1387-2877, 01/2009, Volume 17, Issue 4, pp. 899 - 911
The temporal relationship between depression and cognitive decline has not been extensively investigated in prospective population-based studies, and most of... 
Journal Article
Journal of Alzheimer's Disease, ISSN 1387-2877, 01/2009, Volume 17, Issue 1, pp. 7 - 31
Among lifestyle-related factors, low to moderate alcohol drinking has been proposed as a protective factor against the development of age-related changes in... 
Journal Article
Free Radical Biology and Medicine, ISSN 0891-5849, 10/2017, Volume 111, pp. 173 - 185
Non-alcoholic fatty liver disease (NAFLD) is the major public health challenge for hepatologists in the twenty-first century. NAFLD comprises a histological... 
Lipid peroxidation | Lipid metabolism | Non-alcoholic steatohepatitis | Oxysterols | ACETYL-COA | DE-NOVO LIPOGENESIS | FATTY LIVER-DISEASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | STEAROYL-COA DESATURASE-1 | ACTIVATED RECEPTOR-ALPHA | ENDOPLASMIC-RETICULUM STRESS | NUCLEAR RECEPTOR | INSULIN-RESISTANCE | ENDOCRINOLOGY & METABOLISM | HEPATIC STEATOSIS | ANTISENSE OLIGONUCLEOTIDE INHIBITORS | Non-alcoholic Fatty Liver Disease - pathology | Liver - pathology | Oxidative Stress | Humans | Cytochrome P-450 Enzyme System - metabolism | Non-alcoholic Fatty Liver Disease - complications | Fatty Acid Transport Proteins - metabolism | Liver Cirrhosis - metabolism | Lipid Metabolism - genetics | Fatty Acids - metabolism | Liver Cirrhosis - genetics | Oxysterols - metabolism | Severity of Illness Index | Liver Cirrhosis - etiology | Nuclear Receptor Coactivators - metabolism | Non-alcoholic Fatty Liver Disease - genetics | Oxidation-Reduction | Liver - metabolism | Gene Expression Regulation | Insulin Resistance | Non-alcoholic Fatty Liver Disease - metabolism | Cholesterol - metabolism | Disease Progression | Cytochrome P-450 Enzyme System - genetics | Liver Cirrhosis - pathology | Nuclear Receptor Coactivators - genetics | Fatty Acid Transport Proteins - genetics | Medical research | Bile acids | Liver | Low density lipoproteins | Cytochrome P-450 | Lipids | Transforming growth factors | Aldehydes | Fatty acids | Carnitine | Monounsaturated fatty acids | Synthesis | Physiological aspects | Medicine, Experimental | Insulin resistance | Oxidation-reduction reaction | Liver cirrhosis | Saturated fatty acids | Protein binding
Journal Article
FRONTIERS IN NUTRITION, ISSN 2296-861X, 08/2017, Volume 4, p. 38
Prostate cancer is the second most common cancer in the world among men, and is the fifth most common cause of cancer death among men. The aim of our review... 
VITAMIN-D | METAANALYSIS | Mediterranean diet | DAIRY-PRODUCTS | MENDELIAN RANDOMIZATION | PROSPECTIVE COHORT | MEAT | prostate cancer | nutrition | NUTRITION & DIETETICS | FATTY-ACID | olive oil | BODY-MASS INDEX | POOLED ANALYSIS | obesity | Prostate cancer | Patient outcomes | Risk factors
Journal Article
Journal of Viral Hepatitis, ISSN 1352-0504, 11/2019, Volume 26, Issue 11, pp. 1249 - 1256
The advent of highly effective and well‐tolerated direct antiviral antivirals (DAAs) has dramatically changed the landscape of chronic hepatitis C. The effect... 
older adults | viral hepatitis | direct‐acting antivirals | hepatitis C | Antiviral agents | Medical research | Care and treatment | Analysis | Medicine, Experimental | Aged patients | Hepatitis C virus | Hepatitis C
Journal Article
Journal Article